Skip to content
ppharmaranks
Menu

KANJINTI vs LUTATHERA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. KANJINTI and LUTATHERA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

TRASTUZUMAB-ANNS
LUTETIUM LU 177 DOTATATE

Dosage forms

Injectable
Injectable

Drug class

Boxed warning

Treats

Breast Neoplasms, Gastrointestinal Neoplasms
Gastrointestinal Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

Which is better-rated, Kanjinti or Lutathera?

By our independent rating, Kanjinti scores higher — 3.6 vs 3.5 out of 5 for Lutathera. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Kanjinti and Lutathera?

Kanjinti contains Trastuzumab-Anns, while Lutathera contains Lutetium Lu 177 Dotatate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.